Trial Profile
A phase IIa trial to investigate the efficacy and safety of valproic acid (VAL-001) in patients with diffuse large B-cell lymphoma
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Valproic acid (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 09 Feb 2016 New trial record